Korg just officially unveiled the Phase8 synthesizer, after years of tinkering by a team led by legendary engineer Tatsuya Takahashi. This is a highly experimental synthesizer, but it's not a concept ...
Korg has expanded its catalogue of virtual instruments with the release of Collection 6, a newly-updated version of its suite of software recreations of classic Korg synths. Korg launched its Legacy ...
The new Kronos IEMs from have nine drivers and a six-way crossover but an impedance of less than 35Ω. Noble Audio has announced the launch of its latest pair of flagship in-ear monitors. The Kronos ...
Today (July 16) marks the 80th anniversary of the Trinity test, during which a team of U.S. scientists led by J. Robert Oppenheimer detonated the world’s first atomic bomb in the deserts of New Mexico ...
Investing.com -- S&P Global Ratings downgraded Concord, Ontario-based Kronos Acquisition Holdings Inc. to ’CCC+’ from ’B-’ due to tightening liquidity and ongoing operational challenges. The downgrade ...
(RTTNews) - Kronos Bio (KRON) has entered into a definitive merger agreement with Concentra Biosciences, LLC, whereby Concentra will acquire Kronos Bio for $0.57 in cash per share of Kronos Bio common ...
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. ("Kronos Bio") (Nasdaq: KRON), a biotechnology company that has been developing small molecule therapeutics to address cancers and ...
NAMM 2025: Korg has revived its beloved Kronos workstation, unveiling an updated model that promises to be faster and more flexible then previous incarnations, as well as being packed with fresh ...
Robbie has been an avid gamer for well over 20 years. During that time, he's watched countless franchises rise and fall. He's a big RPG fan but dabbles in a little bit of everything. Writing about ...
New more versatile sound engine. Vocoder, hardtune and harmonizer vocal effects. Solid build. Excellent color screen. The MicroKorg 2 is an improvement on the original in almost every way, that much ...
Kronos Bio, a San Mateo biotech company, is losing millions of dollars a month and recently had to discontinue its sole clinical-stage compound because of adverse side effects. Now, the company is ...
Kronos Q324 sales volumes soared, offsetting flat TiO2 selling prices to deliver +22% YoY revenue growth along with improved profitability. The company faces high growth expectations as it integrates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results